Literature DB >> 20346314

Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.

Mohamed Abdel-Wahab1, Mohammed Saad, Joerg Kynast, Volker Geist, Mohammad A Sherif, Gert Richardt, Ralph Toelg.   

Abstract

Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump counterpulsation (IABP) are established treatment modalities in acute myocardial infarction complicated by cardiogenic shock. We hypothesized that the insertion of the IABP before primary PCI might result in better survival of patients with cardiogenic shock compared to postponing the insertion to after primary PCI. We, therefore, retrospectively studied 48 patients who had undergone primary PCI with IABP because of cardiogenic shock complicating acute myocardial infarction (26 patients received the IABP before and 22 patients after primary PCI). No significant differences were present in the baseline clinical characteristics between the 2 groups. The mean number of diseased vessels was greater in the group of patients treated with the IABP before primary PCI (2.8 +/- 0.5 vs 2.3 +/- 0.7, p = 0.012), but the difference in the number of treated vessels was not significant. The peak creatine kinase and creatine kinase -MB levels were lower in patients treated with the IABP before primary PCI (median 1,077, interquartile range 438 to 2067 vs median 3,299, interquartile range 695 to 6,834, p = 0.047, and median 95, interquartile range 34 to 196 vs median 192, interquartile range 82 to 467, p = 0.048, respectively). In-hospital mortality and the overall incidence of major adverse cardiac and cerebrovascular events were significantly lower in the group of patients receiving the IABP before primary PCI (19% vs 59% and 23% vs 77%, p = 0.007 and p = 0.0004, respectively). Multivariate analysis identified renal failure (odds ratio 15.2, 95% confidence interval 3.13 to 73.66) and insertion of the IABP after PCI (odds ratio 5.2, 95% confidence interval 1.09 to 24.76) as the only independent predictors of in-hospital mortality. In conclusion, the results of the present study suggest that patients with cardiogenic shock complicating acute myocardial infarction who undergo primary PCI assisted by IABP have a more favorable in-hospital outcome and lower in-hospital mortality than patients who receive IABP after PCI. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346314     DOI: 10.1016/j.amjcard.2009.11.021

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  Stenting of complex lesions: an overview.

Authors:  Usman Baber; Annapoorna S Kini; Samin K Sharma
Journal:  Nat Rev Cardiol       Date:  2010-09       Impact factor: 32.419

2.  Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.

Authors:  K D Sjauw; A E Engström; M M Vis; W Boom; J Baan; R J de Winter; J G P Tijssen; J J Piek; J P S Henriques
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

Review 3.  Continuous internal counterpulsation as a bridge to recovery in acute and chronic heart failure.

Authors:  Christos D Kontogiannis; Konstantinos Malliaras; Chris J Kapelios; Jay W Mason; John N Nanas
Journal:  World J Transplant       Date:  2016-03-24

4.  Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.

Authors:  B Schwarz; M Abdel-Wahab; D R Robinson; G Richardt
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-23       Impact factor: 0.840

5.  Trends, Outcomes, and Predictors of Revascularization in Cardiogenic Shock.

Authors:  Muhammad Zia Khan; Muhammad Bilal Munir; Muhammad U Khan; Mohammed Osman; Pratik Agrawal; Moinuddin Syed; Yasir Abdul Ghaffar; Anas Alharbi; Safi U Khan; Sudarshan Balla
Journal:  Am J Cardiol       Date:  2019-11-06       Impact factor: 2.778

Review 6.  Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.

Authors:  Susanne Unverzagt; Michael Buerke; Antoinette de Waha; Johannes Haerting; Diana Pietzner; Melchior Seyfarth; Holger Thiele; Karl Werdan; Uwe Zeymer; Roland Prondzinsky
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

Review 7.  Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure.

Authors:  William E Lawson; Michael Koo
Journal:  Clin Med Insights Cardiol       Date:  2015-04-01

8.  Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry.

Authors:  M Bilal Iqbal; Simon D Robinson; Lillian Ding; Anthony Fung; Eve Aymong; Albert W Chan; Steven Hodge; Anthony Della Siega; Imad J Nadra
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

9.  Is Intra-Aortic Balloon Pump Counterpulsation Sufficient to Treat Patients in Cardiogenic Shock, Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Maria Paton; Lisa Ashton; Ian Pearson; Mohan Sivananthan
Journal:  Cardiol Res       Date:  2015-12-16

10.  Impact of intra-aortic balloon pump on long-term mortality of unselected patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock.

Authors:  Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Paweł Kleczyński; Wojciech Zasada; Dariusz Dudek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-09-11       Impact factor: 1.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.